Research
Interests:
Newborn animals succumb to infections and diseases that have
little to no effect in adults. This disease susceptibility
in early life is at least partially due to the failure to
mount protective immune responses. To understand the basis
for poor responsiveness, we are studying T cell function in
neonates. In particular, we compare the T helper (Th) activities
that arise in situ in neonatal vs. adult mice. Th cells can
be functionally divided into Th1 and Th2 subsets. The Th1
subset produces gamma-IFN and mediates delayed-type hypersensitivity
and protection against intracellular pathogens. The Th2 subset
produces IL-4 and IL-5 and is important in humoral responses.
Immune responses heavily skewed toward Th1 or Th2 function
can exacerbate infectious diseases, allergic reactions, diabetes,
and autoimmunity. Thus, generating and maintaining the appropriate
Th1/Th2 balance is critical for protective immunity. This
is particularly important for the very early stages of life,
when exposure to many novel antigens occurs. Our goal is to
understand how Th1/Th2 responses develop and persist in early
life.
Our
studies have revealed several unique and interesting differences
between the Th responses of newborns and adults. First, unlike
in adult, newborn lymph node and spleen cells show different
responses to immunization with protein antigen; lymph nodes
develop a mature, mixed Th1/Th2 response whereas spleens show
exclusive Th2 development. Second, even in the lymph nodes,
neonatal, but not adult, Th2 function persists for a prolonged
period following a single immunization. Lastly, animals initially
immunized as neonates are ‘programmed’ to have
Th2-dominant memory responses, under conditions in which adults
show Th1 dominance. Thus, there is a significant Th2-skewed
component to all phases of the immune response in neonates.
We are currently striving to identify the cellular and molecular
regulation of this phenomenon.
Selected Publications:
Rose S, Guevara P, Farach S, Adkins B. (2006) The key regulators of adult T helper cell responses, STAT6 and T-bet, are established in early life in mice. Eur J Immunol. 36(5):1241-53.
Adkins, B., Marshall-Clarke, S., and C. LeClerc. (2004) Neonatal adaptive immunity comes of age. Nat. Rev. Immunol. 4:553.
Adkins, B., Jones, M., Bu, Y., and Levy, R.B. (2004) Neonatal tolerance revisited again: specific CTL priming in murine neonates injected with small numbers of semi- or fully-allogeneic spleen cells. Eur. J. Immunol. 34:1901.
Adkins, B. (2003) Peripheral CD4+ lymphocytes derived from fetal vs adult thymic precursors differ phenotypically and functionally. J. Immunol. 171:5157.
Adkins,
B., Williamson, T., Guevara, P., and Bu, Y. (2003) Murine neonatal
lymphocytes show rapid early cell cycle entry and cell division.
J.
Immunol. 170:4548.
Adkins, B.,
Bu, Y., Vincek, V., and P. Guevara. (2003) The primary responses
of murine neonatal lymph node CD4+ cells are Th2-skewed and are
sufficient for the development of Th2-biased memory. Clin. Develop. Immunol. 10:43.
Adkins,
B, Bu, Y. and P. Guevara. (2002) Murine neonatal CD4+ lymph node
cells are highly deficient in the development of antigen specific
Th1 function in adoptive adult hosts.
J. Immunol. 169:4998.
Adkins,
B., Bu, Y., and Guevara, P. (2001) The generation of Th memory in
neonates vs adults: Prolonged primary Th2 effector function and
impaired development of Th1 memory effectors in neonates. J.
Immunol. 166:918-925.
Adkins,
B. (2000) Development of neonatal Th1/Th2 function. Int.
Rev. Immunol. 19:157-171.
Adkins,
B., Bu, Y., Cepero, E., and Perez, R. (2000) Exclusive Th2 primary
effector function in spleens but mixed Th1/Th2 function in lymph
nodes of murine neonates. J.
Immunol. 164:2347-2353.
Adkins,
B. (1999) Apoptosis of naive murine neonatal T cells. Int.
Rev. Immunol. 18:465-484.
Adkins,
B. (1999) T cell function in newborn mice and humans. Immunology
Today, 20:330-335.
Adkins,
B. and Du, R.-D. (1998) Newborn mice develop balanced Th1/Th2 primary
effector responses in vivo but are biased to Th2 secondary responses.
J.Immunol.
160:4217-4224. |